Smith & Nephew plc

NYSE:SNN

Medical - Devices

Healthcare
$30.32 -1.39%

-$0.43 today

Market cap
$12.72B
Beta
0.67
P/E (TTM)
20.1
EPS (TTM)
$0.74
Dividend yield
2.59%
52W Low $28.79High $38.79

Volume 1.22M

Average 1.10M

SNN EBITDA Margin

EBITDA as a percentage of revenue.

Smith & Nephew plcNYSE: SNN

EBITDA Margin · Q4 FY2025 · quarter ended Dec 2025

EBITDA Margin narrows to 19.8%

EBITDA Margin was 19.8% in Q4 FY2025, down 4.8 pp from a year earlier. Over 3 fiscal years it narrowed by 0.4 pp.

Context

  • EBITDA Margin widened in 1 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 7 analysts of 27.4% for the fiscal year ending Dec 2026, up from 21.7% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterDec 2025
19.8%— QoQ
Last fiscal yearDec 2025
21.7%-1.3 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-4.8 pp——
1 year-1.3 pp+5.7 pp+7.0 pp
3 years-0.4 pp+5.9 pp+6.3 pp
5 years+6.2 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2025
21.7%
Year-over-year change
-1.3pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How SNN compares with its peers on the latest reported figures

  • SNN's FY2025 EBITDA Margin of 21.7% is the 4th highest of the 11 companies compared; the peer median is 10.6%.
  • Its year-over-year change of -1.3 pp is the 7th highest of 11, against a peer median of +4.7 pp.
  • Over three fiscal years its change of -0.4 pp compares with a peer median of +2.7 pp.
SNN Competitors Peer median
EBITDA Margin for SNN and competitors
Company Period LTM level YoY 3-year change
GMEDGlobus Medical, Inc.LTM Jun 202630.1% +6.5 pp+0.4 pp
ZBHZimmer Biomet Holdings, Inc.LTM Jun 202627.5% -1.6 pp+5.4 pp
SYKStryker CorporationLTM Jun 202625.9% +5.9 pp+3.4 pp
SNNSmith & Nephew plcFY202521.7% -1.3 pp-0.4 pp
CNMDCONMED CorporationLTM Mar 202612.4% -6.5 pp+10.5 pp
OFIXOrthofix Medical Inc.LTM Mar 202611.5% +13.4 pp-6.1 pp
XTNTXtant Medical Holdings, Inc.LTM Mar 20269.7% +12.3 pp+21.2 pp
ATECAlphatec Holdings, Inc.LTM Mar 2026-0.2% +8.0 pp+24.0 pp
KIDSOrthoPediatrics Corp.LTM Mar 2026-2.7% +3.5 pp+2.1 pp
IARTIntegra LifeSciences Holdings CorporationLTM Mar 2026-17.6% -28.7 pp-44.6 pp
ENOVEnovis CorporationLTM Apr 2026-32.8% -10.9 pp-52.4 pp
Peer median (excluding SNN) 10.6%+4.7 pp+2.7 pp

Competitors are the stored peer set for SNN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue5.21B5.22B5.55B5.81B6.16B
Cost of Revenue1.51B1.52B1.65B1.73B1.96B
Gross Profit3.7B3.7B3.9B4.08B4.21B
Gross Margin71.0%70.9%70.2%70.2%68.3%
Research & Development356M345M339M343M346M
Selling, General & Admin2.64B2.71B2.83B2.9B3.04B
Operating Expenses3.11B3.25B3.47B3.42B3.41B
Depreciation & Amortization507M492M473M449M459M
EBITDA1.22B1.15B1.21B1.34B1.34B
EBITDA Margin23.4%22.1%21.9%23.0%21.7%
Operating Income593M450M425M657M794M
Operating Margin11.4%8.6%7.7%11.3%12.9%
Interest Income6M13.99M34.13M24.01M28.07M
Interest Expense79.99M79.95M132.51M150.06M141.33M
Other Income / Expenses(7M)(215M)(135M)(159M)(15M)
Income Before Tax586M235M290M498M779M
Pre-Tax Margin11.2%4.5%5.2%8.6%12.6%
Income Tax Expense62M12M27M86M154M
Net Income524M223M263M412M625M
Net Margin10.1%4.3%4.7%7.1%10.1%
EPS (Basic)1.200.501.200.941.46
EPS (Diluted)1.200.501.200.941.44
Weighted Avg Shares438.5M437.55M217.75M438.3M433.42M
Weighted Avg Shares (Diluted)438.86M437.55M218.44M438.3M436.47M

Smith & Nephew plc

NYSE:SNN

Intrinsic Alpha fair value

Locked

Current Price

$30.32

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.